Literature DB >> 11720467

Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma.

W Ye1, W H Chow, J Lagergren, P Boffetta, G Boman, H O Adami, O Nyrén.   

Abstract

In the first cohort study of the question we followed 92 986 (42 663 men and 50 323 women) adult patients hospitalized for asthma in Sweden from 1965 to 1994 for an average of 8.5 years to evaluate their risk of oesophageal and gastric cardia adenocarcinoma. Standardized incidence ratio (SIR) adjusted for gender, age and calendar year was used to estimate relative risk, using the Swedish nationwide cancer incidence rates as reference. Asthmatic patients overall had a moderately elevated risk for oesophageal adenocarcinoma (SIR = 1.5, 95% confidence interval CI, 0.9-2.5) and gastric cardia cancer (SIR = 1.4, 95% CI, 1.0-1.9). However, the excess risks were largely confined to asthmatic patients who also had a discharge record of gastro-oesophageal reflux (SIR = 7.5, 95% CI, 1.6-22.0 and SIR = 7.1, 95% CI, 3.1-14.0, respectively). No significant excess risk for oesophageal squamous-cell carcinoma or distal stomach cancer was observed. In conclusion, asthma is associated with a moderately elevated risk of developing oesophageal or gastric cardia adenocarcinoma. Special clinical vigilance vis-à-vis gastro-esophageal cancers seems unwarranted in asthmatic patients, but may be appropriate in those with clinically manifest gastro-oesophageal reflux. Copyright 2001 Cancer Research Campaign

Entities:  

Mesh:

Year:  2001        PMID: 11720467      PMCID: PMC2375235          DOI: 10.1054/bjoc.2001.2094

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

2.  Prevalence of oesophagitis in asthmatics.

Authors:  S J Sontag; T G Schnell; T Q Miller; S Khandelwal; S O'Connell; G Chejfec; H Greenlee; U J Seidel; L Brand
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; H O Adami; O Nyrén
Journal:  Ann Intern Med       Date:  2000-08-01       Impact factor: 25.391

4.  Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.

Authors:  D C Farrow; T L Vaughan; C Sweeney; M D Gammon; W H Chow; H A Risch; J L Stanford; P D Hansten; S T Mayne; J B Schoenberg; H Rotterdam; H Ahsan; A B West; R Dubrow; J F Fraumeni; W J Blot
Journal:  Cancer Causes Control       Date:  2000-03       Impact factor: 2.506

5.  Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol.

Authors:  R S Irwin; F J Curley; C L French
Journal:  Chest       Date:  1993-06       Impact factor: 9.410

6.  Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry.

Authors:  B Mattsson; L E Rutqvist; A Wallgren
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

7.  Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy.

Authors:  S J Sontag; S O'Connell; S Khandelwal; T Miller; B Nemchausky; T G Schnell; R Serlovsky
Journal:  Gastroenterology       Date:  1990-09       Impact factor: 22.682

8.  An interview study to estimate prevalence of asthma and chronic bronchitis. The obstructive lung disease in northern Sweden study.

Authors:  B Lundbäck; N Stjernberg; L Nyström; K Lundbäck; M Lindström; L Rosenhall
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

9.  Oesophageal function in asthmatics.

Authors:  G Kjellén; A Brundin; L Tibbling; B Wranne
Journal:  Eur J Respir Dis       Date:  1981

10.  Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden.

Authors:  L E Hansson; P Sparén; O Nyrén
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

View more
  5 in total

Review 1.  Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.

Authors:  Joel H Rubenstein; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2015-05-07       Impact factor: 22.682

2.  Risk factors for the gastric cardia cancer: a case-control study in Fujian Province.

Authors:  Lin Cai; Zong-Li Zheng; Zuo-Feng Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 3.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

4.  Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.

Authors:  Kevin M Reavis; Cynthia D Morris; Deepak V Gopal; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

5.  Cancer risk in hospitalised asthma patients.

Authors:  J Ji; X Shu; X Li; K Sundquist; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.